From: Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression
Features | No. | Nuclear Oct4 immunoreactivity | Nuclear KPNA2 immunoreactivity | ||||
---|---|---|---|---|---|---|---|
Negative | Positive (%) | P | Negative | Positive (%) | P | ||
Age (years) | Â | Â | Â | Â | Â | Â | Â |
<60 | 50 | 36(72.0) | 14(28.0) | 0.925 | 25(50.0) | 25(50.0) | 0.329 |
≥60 | 52 | 37(71.2) | 15(28.8) |  | 21(40.4) | 31(59.6) |  |
Gender | Â | Â | Â | Â | Â | Â | Â |
Male | 59 | 42(71.2) | 17(28.8) | 0.920 | 28(47.5) | 31(52.5) | 0.574 |
Female | 43 | 31(72.1) | 12(27.9) | Â | 18(41.9) | 25(58.1) | Â |
Smoke | Â | Â | Â | Â | Â | Â | Â |
Yes | 52 | 36(69.2) | 16(30.8) | 0.593 | 22(42.3) | 30(57.7) | 0.563 |
No | 50 | 37(74.0) | 13(26.0) | Â | 24(48.0) | 26(52.0) | Â |
Histology | Â | Â | Â | Â | Â | Â | Â |
Adenocarcinoma | 60 | 41(68.3) | 19(31.7) | 0.387 | 35(58.3) | 25(41.7) | 0.001* |
Squamous cell | 42 | 32(72.6) | 10(23.8) | Â | 11(26.2) | 31(73.8) | Â |
Carcinoma | Â | Â | Â | Â | Â | Â | Â |
Differentiation | Â | Â | Â | Â | Â | Â | Â |
Well | 38 | 34(89.5) | 4(10.5) | 0.002* | 22(57.9) | 16(42.1) | 0.045* |
Moderate-Poor | 64 | 39(60.9) | 25(39.1) | Â | 24(37.5) | 40(62.5) | Â |
TNM stage | Â | Â | Â | Â | Â | Â | Â |
I/II | 55 | 46(83.6) | 9(16.4) | 0.003* | 29(52.7) | 26(47.3) | 0.093 |
III/IV | 47 | 27(57.4) | 20(42.6) | Â | 17(36.2) | 30(63.8) | Â |
Angiolymphatic invasion | Â | Â | Â | Â | Â | Â | Â |
No | 57 | 44(77.2) | 13(22.8) | 0.156 | 25(43.9) | 32(56.1) | 0.777 |
Yes | 45 | 29(64.4) | 16(35.6) | Â | 21(46.7) | 24(53.3) | Â |